Crispr Therapeutics Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

The CRISPR Therapeutics Market size was valued at US$ 172.28 Million in 2025 and is projected to reach US$ 4771.17 Million by 2033, growing at a CAGR of 51.46% during 2026–2033, driven by gene-editing advancements, increasing clinical adoption, expanding therapeutic pipelines, regulatory support, and investment opportunities in precision medicine applications.

Report Coverage

Product: CASGEVY, Others
Indication: Sickle Cell Disease, Transfusion-Dependent Beta Thalassemia, Others
Age Group: Pediatric, Adult
End User: Hospitals, Specialty Treatment Centers, Others

US$ 172.28 Mn Market size in 2025

US$ 4771.17 Mn Market Size by 2033

51.46% CAGR, 2026 - 2033

2026-2033 Forecast Period

Download Sample PDF Buy Now

Format PDF + Excel + PPT

No. of Pages: 350

Category Life Sciences

Report Code: BMIPUB00037547

Last Updated: 2026-08-17

Author

Krishna Sunthwal

Analyst Connect

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Crispr Therapeutics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Crispr Therapeutics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Crispr Therapeutics Market Global Analysis

6.2 Crispr Therapeutics Market Revenue 2022-2033 (US$ Million)

6.3 Crispr Therapeutics Market Forecast Analysis

7. Crispr Therapeutics Market Analysis – by Product

7.1 CASGEVY

7.1.1 Overview
7.1.2 CASGEVY: Crispr Therapeutics Market – Revenue and Forecast, 2022-2033 (US$ Million)

7.2 Others

7.2.1 Overview
7.2.2 Others: Crispr Therapeutics Market – Revenue and Forecast, 2022-2033 (US$ Million)

8. Crispr Therapeutics Market Analysis – by Indication

8.1 Sickle Cell Disease

8.1.1 Overview
8.1.2 Sickle Cell Disease: Crispr Therapeutics Market – Revenue and Forecast, 2022-2033 (US$ Million)

8.2 Transfusion-Dependent Beta Thalassemia

8.2.1 Overview
8.2.2 Transfusion-Dependent Beta Thalassemia: Crispr Therapeutics Market – Revenue and Forecast, 2022-2033 (US$ Million)

8.3 Others

8.3.1 Overview
8.3.2 Others: Crispr Therapeutics Market – Revenue and Forecast, 2022-2033 (US$ Million)

9. Crispr Therapeutics Market Analysis – by Age Group

9.1 Pediatric

9.1.1 Overview
9.1.2 Pediatric: Crispr Therapeutics Market – Revenue and Forecast, 2022-2033 (US$ Million)

9.2 Adult

9.2.1 Overview
9.2.2 Adult: Crispr Therapeutics Market – Revenue and Forecast, 2022-2033 (US$ Million)

10. Crispr Therapeutics Market Analysis – by End User

10.1 Hospitals

10.1.1 Overview
10.1.2 Hospitals: Crispr Therapeutics Market – Revenue and Forecast, 2022-2033 (US$ Million)

10.2 Specialty Treatment Centers

10.2.1 Overview
10.2.2 Specialty Treatment Centers: Crispr Therapeutics Market – Revenue and Forecast, 2022-2033 (US$ Million)

10.3 Others

10.3.1 Overview
10.3.2 Others: Crispr Therapeutics Market – Revenue and Forecast, 2022-2033 (US$ Million)

11. Crispr Therapeutics Market – Geographic Analysis

11.1 Overview

11.2 North America

11.2.1 Crispr Therapeutics Market Breakdown, by Key Country, 2026 and 2033 (%)
11.2.1.1 Crispr Therapeutics Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.2.1.1.1 US: Crispr Therapeutics Market Breakdown, by Product
11.2.1.1.2 US: Crispr Therapeutics Market Breakdown, by Indication
11.2.1.1.3 US: Crispr Therapeutics Market Breakdown, by Age Group
11.2.1.1.4 US: Crispr Therapeutics Market Breakdown, by End User

11.2.1.2 Canada: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.2.1.2.1 Canada: Crispr Therapeutics Market Breakdown, by Product
11.2.1.2.2 Canada: Crispr Therapeutics Market Breakdown, by Indication
11.2.1.2.3 Canada: Crispr Therapeutics Market Breakdown, by Age Group
11.2.1.2.4 Canada: Crispr Therapeutics Market Breakdown, by End User

11.2.1.3 Mexico : Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.2.1.3.1 Mexico : Crispr Therapeutics Market Breakdown, by Product
11.2.1.3.2 Mexico : Crispr Therapeutics Market Breakdown, by Indication
11.2.1.3.3 Mexico : Crispr Therapeutics Market Breakdown, by Age Group
11.2.1.3.4 Mexico : Crispr Therapeutics Market Breakdown, by End User

11.3 Europe

11.3.1 Crispr Therapeutics Market Breakdown, by Key Country, 2026 and 2033 (%)
11.3.1.1 Crispr Therapeutics Market – Revenue and Forecast Analysis – by Country
11.3.1.1 Germany: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.1.1 Germany: Crispr Therapeutics Market Breakdown, by Product
11.3.1.1.2 Germany: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.1.3 Germany: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.1.4 Germany: Crispr Therapeutics Market Breakdown, by End User

11.3.1.2 Italy: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.2.1 Italy: Crispr Therapeutics Market Breakdown, by Product
11.3.1.2.2 Italy: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.2.3 Italy: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.2.4 Italy: Crispr Therapeutics Market Breakdown, by End User

11.3.1.3 France: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.3.1 France: Crispr Therapeutics Market Breakdown, by Product
11.3.1.3.2 France: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.3.3 France: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.3.4 France: Crispr Therapeutics Market Breakdown, by End User

11.3.1.4 U.K.: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.4.1 U.K.: Crispr Therapeutics Market Breakdown, by Product
11.3.1.4.2 U.K.: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.4.3 U.K.: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.4.4 U.K.: Crispr Therapeutics Market Breakdown, by End User

11.3.1.5 Spain: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.5.1 Spain: Crispr Therapeutics Market Breakdown, by Product
11.3.1.5.2 Spain: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.5.3 Spain: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.5.4 Spain: Crispr Therapeutics Market Breakdown, by End User

11.3.1.6 Belgium: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.6.1 Belgium: Crispr Therapeutics Market Breakdown, by Product
11.3.1.6.2 Belgium: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.6.3 Belgium: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.6.4 Belgium: Crispr Therapeutics Market Breakdown, by End User

11.3.1.7 Netherlands: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.7.1 Netherlands: Crispr Therapeutics Market Breakdown, by Product
11.3.1.7.2 Netherlands: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.7.3 Netherlands: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.7.4 Netherlands: Crispr Therapeutics Market Breakdown, by End User

11.3.1.8 Luxembourg: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.8.1 Luxembourg: Crispr Therapeutics Market Breakdown, by Product
11.3.1.8.2 Luxembourg: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.8.3 Luxembourg: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.8.4 Luxembourg: Crispr Therapeutics Market Breakdown, by End User

11.3.1.9 Norway: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.9.1 Norway: Crispr Therapeutics Market Breakdown, by Product
11.3.1.9.2 Norway: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.9.3 Norway: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.9.4 Norway: Crispr Therapeutics Market Breakdown, by End User

11.3.1.10 Finland: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.10.1 Finland: Crispr Therapeutics Market Breakdown, by Product
11.3.1.10.2 Finland: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.10.3 Finland: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.10.4 Finland: Crispr Therapeutics Market Breakdown, by End User

11.3.1.11 Denmark: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.11.1 Denmark: Crispr Therapeutics Market Breakdown, by Product
11.3.1.11.2 Denmark: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.11.3 Denmark: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.11.4 Denmark: Crispr Therapeutics Market Breakdown, by End User

11.3.1.12 Sweden: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.12.1 Sweden: Crispr Therapeutics Market Breakdown, by Product
11.3.1.12.2 Sweden: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.12.3 Sweden: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.12.4 Sweden: Crispr Therapeutics Market Breakdown, by End User

11.3.1.13 Switzerland: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.13.1 Switzerland: Crispr Therapeutics Market Breakdown, by Product
11.3.1.13.2 Switzerland: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.13.3 Switzerland: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.13.4 Switzerland: Crispr Therapeutics Market Breakdown, by End User

11.3.1.14 Austria: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.14.1 Austria: Crispr Therapeutics Market Breakdown, by Product
11.3.1.14.2 Austria: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.14.3 Austria: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.14.4 Austria: Crispr Therapeutics Market Breakdown, by End User

11.3.1.15 Greece: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.15.1 Greece: Crispr Therapeutics Market Breakdown, by Product
11.3.1.15.2 Greece: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.15.3 Greece: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.15.4 Greece: Crispr Therapeutics Market Breakdown, by End User

11.3.1.16 Portugal: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.16.1 Portugal: Crispr Therapeutics Market Breakdown, by Product
11.3.1.16.2 Portugal: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.16.3 Portugal: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.16.4 Portugal: Crispr Therapeutics Market Breakdown, by End User

11.3.1.17 Russia: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.17.1 Russia: Crispr Therapeutics Market Breakdown, by Product
11.3.1.17.2 Russia: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.17.3 Russia: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.17.4 Russia: Crispr Therapeutics Market Breakdown, by End User

11.3.1.18 Poland: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.18.1 Poland: Crispr Therapeutics Market Breakdown, by Product
11.3.1.18.2 Poland: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.18.3 Poland: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.18.4 Poland: Crispr Therapeutics Market Breakdown, by End User

11.3.1.19 Romania: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.19.1 Romania: Crispr Therapeutics Market Breakdown, by Product
11.3.1.19.2 Romania: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.19.3 Romania: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.19.4 Romania: Crispr Therapeutics Market Breakdown, by End User

11.3.1.20 Czech Republic: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.20.1 Czech Republic: Crispr Therapeutics Market Breakdown, by Product
11.3.1.20.2 Czech Republic: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.20.3 Czech Republic: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.20.4 Czech Republic: Crispr Therapeutics Market Breakdown, by End User

11.3.1.21 Ukraine: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.21.1 Ukraine: Crispr Therapeutics Market Breakdown, by Product
11.3.1.21.2 Ukraine: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.21.3 Ukraine: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.21.4 Ukraine: Crispr Therapeutics Market Breakdown, by End User

11.3.1.22 Slovakia: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.22.1 Slovakia: Crispr Therapeutics Market Breakdown, by Product
11.3.1.22.2 Slovakia: Crispr Therapeutics Market Breakdown, by Indication
11.3.1.22.3 Slovakia: Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.22.4 Slovakia: Crispr Therapeutics Market Breakdown, by End User

11.3.1.23 Bulgaria : Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.3.1.23.1 Bulgaria : Crispr Therapeutics Market Breakdown, by Product
11.3.1.23.2 Bulgaria : Crispr Therapeutics Market Breakdown, by Indication
11.3.1.23.3 Bulgaria : Crispr Therapeutics Market Breakdown, by Age Group
11.3.1.23.4 Bulgaria : Crispr Therapeutics Market Breakdown, by End User

11.4 Asia-Pacific

11.4.1 Crispr Therapeutics Market Breakdown, by Key Country, 2026 and 2033 (%)
11.4.1.1 Crispr Therapeutics Market – Revenue and Forecast Analysis – by Country
11.4.1.1 China: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.4.1.1.1 China: Crispr Therapeutics Market Breakdown, by Product
11.4.1.1.2 China: Crispr Therapeutics Market Breakdown, by Indication
11.4.1.1.3 China: Crispr Therapeutics Market Breakdown, by Age Group
11.4.1.1.4 China: Crispr Therapeutics Market Breakdown, by End User

11.4.1.2 Japan: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.4.1.2.1 Japan: Crispr Therapeutics Market Breakdown, by Product
11.4.1.2.2 Japan: Crispr Therapeutics Market Breakdown, by Indication
11.4.1.2.3 Japan: Crispr Therapeutics Market Breakdown, by Age Group
11.4.1.2.4 Japan: Crispr Therapeutics Market Breakdown, by End User

11.4.1.3 South Korea: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.4.1.3.1 South Korea: Crispr Therapeutics Market Breakdown, by Product
11.4.1.3.2 South Korea: Crispr Therapeutics Market Breakdown, by Indication
11.4.1.3.3 South Korea: Crispr Therapeutics Market Breakdown, by Age Group
11.4.1.3.4 South Korea: Crispr Therapeutics Market Breakdown, by End User

11.4.1.4 India: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.4.1.4.1 India: Crispr Therapeutics Market Breakdown, by Product
11.4.1.4.2 India: Crispr Therapeutics Market Breakdown, by Indication
11.4.1.4.3 India: Crispr Therapeutics Market Breakdown, by Age Group
11.4.1.4.4 India: Crispr Therapeutics Market Breakdown, by End User

11.4.1.5 Australia: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.4.1.5.1 Australia: Crispr Therapeutics Market Breakdown, by Product
11.4.1.5.2 Australia: Crispr Therapeutics Market Breakdown, by Indication
11.4.1.5.3 Australia: Crispr Therapeutics Market Breakdown, by Age Group
11.4.1.5.4 Australia: Crispr Therapeutics Market Breakdown, by End User

11.4.1.6 New Zealand: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.4.1.6.1 New Zealand: Crispr Therapeutics Market Breakdown, by Product
11.4.1.6.2 New Zealand: Crispr Therapeutics Market Breakdown, by Indication
11.4.1.6.3 New Zealand: Crispr Therapeutics Market Breakdown, by Age Group
11.4.1.6.4 New Zealand: Crispr Therapeutics Market Breakdown, by End User

11.4.1.7 Indonesia: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.4.1.7.1 Indonesia: Crispr Therapeutics Market Breakdown, by Product
11.4.1.7.2 Indonesia: Crispr Therapeutics Market Breakdown, by Indication
11.4.1.7.3 Indonesia: Crispr Therapeutics Market Breakdown, by Age Group
11.4.1.7.4 Indonesia: Crispr Therapeutics Market Breakdown, by End User

11.4.1.8 Malaysia: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.4.1.8.1 Malaysia: Crispr Therapeutics Market Breakdown, by Product
11.4.1.8.2 Malaysia: Crispr Therapeutics Market Breakdown, by Indication
11.4.1.8.3 Malaysia: Crispr Therapeutics Market Breakdown, by Age Group
11.4.1.8.4 Malaysia: Crispr Therapeutics Market Breakdown, by End User

11.4.1.9 Philippines: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.4.1.9.1 Philippines: Crispr Therapeutics Market Breakdown, by Product
11.4.1.9.2 Philippines: Crispr Therapeutics Market Breakdown, by Indication
11.4.1.9.3 Philippines: Crispr Therapeutics Market Breakdown, by Age Group
11.4.1.9.4 Philippines: Crispr Therapeutics Market Breakdown, by End User

11.4.1.10 Singapore: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.4.1.10.1 Singapore: Crispr Therapeutics Market Breakdown, by Product
11.4.1.10.2 Singapore: Crispr Therapeutics Market Breakdown, by Indication
11.4.1.10.3 Singapore: Crispr Therapeutics Market Breakdown, by Age Group
11.4.1.10.4 Singapore: Crispr Therapeutics Market Breakdown, by End User

11.4.1.11 Thailand: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.4.1.11.1 Thailand: Crispr Therapeutics Market Breakdown, by Product
11.4.1.11.2 Thailand: Crispr Therapeutics Market Breakdown, by Indication
11.4.1.11.3 Thailand: Crispr Therapeutics Market Breakdown, by Age Group
11.4.1.11.4 Thailand: Crispr Therapeutics Market Breakdown, by End User

11.4.1.12 Vietnam: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.4.1.12.1 Vietnam: Crispr Therapeutics Market Breakdown, by Product
11.4.1.12.2 Vietnam: Crispr Therapeutics Market Breakdown, by Indication
11.4.1.12.3 Vietnam: Crispr Therapeutics Market Breakdown, by Age Group
11.4.1.12.4 Vietnam: Crispr Therapeutics Market Breakdown, by End User

11.4.1.13 Taiwan: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.4.1.13.1 Taiwan: Crispr Therapeutics Market Breakdown, by Product
11.4.1.13.2 Taiwan: Crispr Therapeutics Market Breakdown, by Indication
11.4.1.13.3 Taiwan: Crispr Therapeutics Market Breakdown, by Age Group
11.4.1.13.4 Taiwan: Crispr Therapeutics Market Breakdown, by End User

11.4.1.14 Bangladesh : Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.4.1.14.1 Bangladesh : Crispr Therapeutics Market Breakdown, by Product
11.4.1.14.2 Bangladesh : Crispr Therapeutics Market Breakdown, by Indication
11.4.1.14.3 Bangladesh : Crispr Therapeutics Market Breakdown, by Age Group
11.4.1.14.4 Bangladesh : Crispr Therapeutics Market Breakdown, by End User

11.5 South and Central America

11.5.1 Crispr Therapeutics Market Breakdown, by Key Country, 2026 and 2033 (%)
11.5.1.1 Crispr Therapeutics Market – Revenue and Forecast Analysis – by Country
11.5.1.1 Brazil: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.5.1.1.1 Brazil: Crispr Therapeutics Market Breakdown, by Product
11.5.1.1.2 Brazil: Crispr Therapeutics Market Breakdown, by Indication
11.5.1.1.3 Brazil: Crispr Therapeutics Market Breakdown, by Age Group
11.5.1.1.4 Brazil: Crispr Therapeutics Market Breakdown, by End User

11.5.1.2 Argentina: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.5.1.2.1 Argentina: Crispr Therapeutics Market Breakdown, by Product
11.5.1.2.2 Argentina: Crispr Therapeutics Market Breakdown, by Indication
11.5.1.2.3 Argentina: Crispr Therapeutics Market Breakdown, by Age Group
11.5.1.2.4 Argentina: Crispr Therapeutics Market Breakdown, by End User

11.5.1.3 Chile: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.5.1.3.1 Chile: Crispr Therapeutics Market Breakdown, by Product
11.5.1.3.2 Chile: Crispr Therapeutics Market Breakdown, by Indication
11.5.1.3.3 Chile: Crispr Therapeutics Market Breakdown, by Age Group
11.5.1.3.4 Chile: Crispr Therapeutics Market Breakdown, by End User

11.5.1.4 Colombia: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.5.1.4.1 Colombia: Crispr Therapeutics Market Breakdown, by Product
11.5.1.4.2 Colombia: Crispr Therapeutics Market Breakdown, by Indication
11.5.1.4.3 Colombia: Crispr Therapeutics Market Breakdown, by Age Group
11.5.1.4.4 Colombia: Crispr Therapeutics Market Breakdown, by End User

11.5.1.5 Peru : Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.5.1.5.1 Peru : Crispr Therapeutics Market Breakdown, by Product
11.5.1.5.2 Peru : Crispr Therapeutics Market Breakdown, by Indication
11.5.1.5.3 Peru : Crispr Therapeutics Market Breakdown, by Age Group
11.5.1.5.4 Peru : Crispr Therapeutics Market Breakdown, by End User

11.6 Middle East and Africa

11.6.1 Crispr Therapeutics Market Breakdown, by Key Country, 2026 and 2033 (%)
11.6.1.1 Crispr Therapeutics Market – Revenue and Forecast Analysis – by Country
11.6.1.1 Saudi Arabia: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.6.1.1.1 Saudi Arabia: Crispr Therapeutics Market Breakdown, by Product
11.6.1.1.2 Saudi Arabia: Crispr Therapeutics Market Breakdown, by Indication
11.6.1.1.3 Saudi Arabia: Crispr Therapeutics Market Breakdown, by Age Group
11.6.1.1.4 Saudi Arabia: Crispr Therapeutics Market Breakdown, by End User

11.6.1.2 United Arab Emirates: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.6.1.2.1 United Arab Emirates: Crispr Therapeutics Market Breakdown, by Product
11.6.1.2.2 United Arab Emirates: Crispr Therapeutics Market Breakdown, by Indication
11.6.1.2.3 United Arab Emirates: Crispr Therapeutics Market Breakdown, by Age Group
11.6.1.2.4 United Arab Emirates: Crispr Therapeutics Market Breakdown, by End User

11.6.1.3 Kuwait: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.6.1.3.1 Kuwait: Crispr Therapeutics Market Breakdown, by Product
11.6.1.3.2 Kuwait: Crispr Therapeutics Market Breakdown, by Indication
11.6.1.3.3 Kuwait: Crispr Therapeutics Market Breakdown, by Age Group
11.6.1.3.4 Kuwait: Crispr Therapeutics Market Breakdown, by End User

11.6.1.4 Bahrain: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.6.1.4.1 Bahrain: Crispr Therapeutics Market Breakdown, by Product
11.6.1.4.2 Bahrain: Crispr Therapeutics Market Breakdown, by Indication
11.6.1.4.3 Bahrain: Crispr Therapeutics Market Breakdown, by Age Group
11.6.1.4.4 Bahrain: Crispr Therapeutics Market Breakdown, by End User

11.6.1.5 Qatar: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.6.1.5.1 Qatar: Crispr Therapeutics Market Breakdown, by Product
11.6.1.5.2 Qatar: Crispr Therapeutics Market Breakdown, by Indication
11.6.1.5.3 Qatar: Crispr Therapeutics Market Breakdown, by Age Group
11.6.1.5.4 Qatar: Crispr Therapeutics Market Breakdown, by End User

11.6.1.6 Oman: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.6.1.6.1 Oman: Crispr Therapeutics Market Breakdown, by Product
11.6.1.6.2 Oman: Crispr Therapeutics Market Breakdown, by Indication
11.6.1.6.3 Oman: Crispr Therapeutics Market Breakdown, by Age Group
11.6.1.6.4 Oman: Crispr Therapeutics Market Breakdown, by End User

11.6.1.7 Turkiye: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.6.1.7.1 Turkiye: Crispr Therapeutics Market Breakdown, by Product
11.6.1.7.2 Turkiye: Crispr Therapeutics Market Breakdown, by Indication
11.6.1.7.3 Turkiye: Crispr Therapeutics Market Breakdown, by Age Group
11.6.1.7.4 Turkiye: Crispr Therapeutics Market Breakdown, by End User

11.6.1.8 South Africa: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.6.1.8.1 South Africa: Crispr Therapeutics Market Breakdown, by Product
11.6.1.8.2 South Africa: Crispr Therapeutics Market Breakdown, by Indication
11.6.1.8.3 South Africa: Crispr Therapeutics Market Breakdown, by Age Group
11.6.1.8.4 South Africa: Crispr Therapeutics Market Breakdown, by End User

11.6.1.9 Egypt: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.6.1.9.1 Egypt: Crispr Therapeutics Market Breakdown, by Product
11.6.1.9.2 Egypt: Crispr Therapeutics Market Breakdown, by Indication
11.6.1.9.3 Egypt: Crispr Therapeutics Market Breakdown, by Age Group
11.6.1.9.4 Egypt: Crispr Therapeutics Market Breakdown, by End User

11.6.1.10 Nigeria: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.6.1.10.1 Nigeria: Crispr Therapeutics Market Breakdown, by Product
11.6.1.10.2 Nigeria: Crispr Therapeutics Market Breakdown, by Indication
11.6.1.10.3 Nigeria: Crispr Therapeutics Market Breakdown, by Age Group
11.6.1.10.4 Nigeria: Crispr Therapeutics Market Breakdown, by End User

11.6.1.11 Algeria: Crispr Therapeutics Market – Revenue and Forecast to 2033 (US$ Million)

11.6.1.11.1 Algeria: Crispr Therapeutics Market Breakdown, by Product
11.6.1.11.2 Algeria: Crispr Therapeutics Market Breakdown, by Indication
11.6.1.11.3 Algeria: Crispr Therapeutics Market Breakdown, by Age Group
11.6.1.11.4 Algeria: Crispr Therapeutics Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 CRISPR Therapeutics AG

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Prime Medicine, Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Caribou Biosciences, Inc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Regeneron Pharmaceuticals, Inc.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Sangamo Therapeutics, Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Metagenomi, Inc.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Graphite Bio, Inc.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Scribe Therapeutics

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Novartis AG

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Precision BioSciences, Inc.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Access the Full C Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization